Light normalizing intraocular lenses

International Ophthalmology Clinics

Volumn 45, Issue 1, 2005, Pages 55-106

  Davison, James A ^a   Patel, Anil S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CATARACT EXTRACTION; DEVICE; HUMAN; LENS IMPLANT; LIGHT NORMALIZING INTRAOCULAR LENS; NONHUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; VISION;

AGING; ANIMALS; FILTRATION; HUMANS; LENSES, INTRAOCULAR; LIGHT; MACULAR DEGENERATION; PSEUDOPHAKIA; ULTRAVIOLET RAYS;

EID: 13244298185     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (214)

1. Hyman L. Epidemiology of eye disease in the elderly. Eye. 1987;1:330-341.
2. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology. 1996; 103:1721-1726.
3. Leaming DV. Estimated annualized volumes for cataract surgery ASCRS members 2000. Available at: http://www.analeyz.com. Accessed August 10, 2004.
4. Hyman L. Epidemiology of advanced AMD. In: Hampton RG, Nelson PT, eds. Age-Related Modular Degeneration: Principles and Practice. New York, NY: Raven Press; 1992:1-35.
5. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825.
6. Blair CJ, Ferguson J Jr. Exacerbation of senile macular degeneration following cataract extraction. Am J Ophthalmol. 1979;87:77-83.
7. van de Schaft TL, Mooy CM, de Bruijin WC, et al. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol. 1994;78:441-445.
8. Pollack A, Marcovich A, Bukelman A, et al. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology. 1996;103:1546-1554.
9. Pollack A, Marcovich A, Bukelman A, et al. Development of exudative age-related macular degeneration after cataract surgery. Eye. 1997;11:523-530.
10. Hawkins WR. AMD after ECCE with IOL implant [letter]. Ophthalmology. 1997;104: 900.
11. Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA study group. Br J Ophthalmol. 1998;82:996-1002.
12. Klein R, Klein BE, Jensen SC, et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol. 1998;116:506-513.
13. Ridley H. Intra-ocular acrylic lenses. Trans Ophthalmol Soc UK. 1951;71:617-621.
14. Ridley H. Intra-ocular acrylic lenses; a recent development in the surgery of cataract. Br J Ophthalmol. 1952;36:113-122.
15. Mainster MA. Solar retinitis, photic maculopathy and the pseudophakic eye. J Am Intraocul Implant Soc. 1978;4:84-86.
16. Mainster MA. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol. 1978;85:167-170.
17. Zigman S. Spectral transmittance of intraocular lenses. Am J Ophthalmol. 1978;85:878-879.
18. Clayman HM. Ultraviolet-absorbing intraocular lenses. J Am Intraocul Implant Soc. 1984;10:429-432.
19. Peyman GA, Sloan HD, Lim J. Ultraviolet light absorbing pseudophakos. J Am Intraocul Implant Soc. 1982;8:357-360.
20. Kraff MC, Sanders DR, Jampol LM, et al. Factors affecting pseudophakic cystoid macular edema: five randomized trials. J Am Intraocul Implant Soc. 1985;11:380-385.
21. Kraff MC, Sanders DR, Jampol LM, et al. Effect of an ultraviolet- filtering intraocular lens on cystoid macular edema. Ophthalmology. 1985;92:366-369.
22. Mainster MA, Sparrow JR. How much blue light should an IOL transmit? Br J Ophthalmol. 2003;87:1523-1529.
23. Boettner EA, Woher JR. Transmission of the ocular media. Invest Ophthalmol. 1962;1: 776-783.
24. Cooper GF, Robson JG. The yellow color of the lens of man and other primates. J Physiol. 1969;203:411-417.
25. Zigman S. Eye lens color. Formation and function. Science. 1971;171:807-809.
26. Zigman S. Tinting of intraocular lens implants. Arch Ophthalmol. 1982;100:998.
27. Sliney DH. Eye protective techniques for bright light. Ophthalmology. 1983;90:937-944.
28. Marshall J. Radiation and the ageing eye. Ophthalmic Physiol Opt. 1985;5:241-264.
29. Fishman GA. Ocular phototoxicity: guidelines for selecting sunglasses. Surv Ophthalmol. 1986;31:119-124.
30. Rosen ES. Pseudophakia and hazards of non-ionizing radiation. Semin Ophthalmol. 1986; 1:68-79.
31. Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye. 1987;1:304-310.
32. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987; 31:291-306.
33. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol. 1988; 32:252-269.
34. Kelman C. Phaco-emulsification and aspiration. A new technique of cataract removal. A preliminary report. Am J Ophthalmol. 1967;64:23-45.
35. Patel AS, Hovnaian HP, Kozar E. UV curing of dental materials. AFP SME Technical paper FC76-513. Dearborn, MI: The Association for Finishing Processes of Society of Manufacturing Engineers; 1976.
36. Daicho M, Yokoyama Y, Tsuchiya M. Process of Producing Cyanopsia-Correctable Intraocular Lens. 1994; US patent no. 5,374,663.
37. Ichikawa K, Tamaoki A, Ichikawa H. The color sense of pseudophakic eyes: chromatopsia. In: Ohta Y, ed. Color Vision Deficiencies: Proceedings of the Symposium of the International Research Group in Color Vision Deficiencies, Tokyo Japan, March 26-28, 1990. Amsterdam: Kugler & Ghedini Publication; 1990:237-243.
38. Machida S, Fukuda A, Mori T, et al. [Color sensation of pseudophakic eye from a viewpoint of electrophysiological study.] [in Japanese]. Nippon Ganka Gakkai Zasshi. 1992;96:784-789.
39. Ishida M, Yanashima K, Miwa W, et al. [Influence of the yellow-tinted intraocular lens on spectral sensitivity.] [in Japanese]. Nippon Ganka Gakkai Zasshi. 1994;98:192-196.
40. Mantyjarvi M, Syrjakoski J, Tuppuraninen K, et al. Colour vision through intraocular lens. Acta Ophthalmol Scand. 1997;75:166-169.
41. Shimuzu H, Tsurimaki Y, Onishi S, et al. [Results of UVCY PCL implantation in 120 consecutive eyes.] [in Japanese with abstract in English]. Japan J Ophthal Surg. 1993;6: 453-456.
42. Niwa K, Yoshino Y, Okuyama F, et al. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt. 1996;16:297-302.
43. Miyake K, Ichihashi S, Shibuya Y, et al. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg. 1999; 25:891-897.
44. Ichikawa K. Tinted Foldable Silicone IOL. Symposium on Cataract, IOL and Refractive Surgery, May 1-5, 2004, San Diego. Fairfax, VA: ASCRS Abstracts; 2004:217.
45. Lindqvist B, Hogstrom B, Sandberg M, et al. UV Absorbing Lens Material. 1989: US patent no. 4,795,461.
46. Nilsson SE, Textorius O, Anderson BE, et al. Clear PMMA versus yellow intraocular lens material. An electrophysiologic study on pigmented rabbits regarding "the blue light hazard." Prog Clin Biol Res. 1989;314:539-553.
47. Nilsson SE, Textorius O, Anderson BE, et al. Does blue light absorbing IOL material protect the neuro-retina and pigment epithelium better than currently used materials? Lasers Light Ophthalmol. 1990;3:1-10.
48. Le Grand Y. Light, Colour and Vision. London: Chapman & Hill; 1957.
49. International Commission on Non-ionizing Radiation Protection. Guidelines on limits of exposure to broad-band incoherent optical radiation (0.38 to 3 microM). Health Phys. 1997;73:539-554.
50. Wooten BR, Hammond BR, Land RI, et al. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40:2481-2489.
51. Zigman S. Near-UV light and cataracts. Photochem Photobiol. 1977;26:437-441.
52. Zigman S. Ultraviolet light and human lens pigmentation. Vision Res. 1978;18:509-510.
53. Klein R, Davis M, Magli Y, et al. The Wisconsin Age-related Maculopathy Grading System. Ophthalmology. 1991;98:1128-1134.
54. Lerman S. Radiant Energy and the Eye. New York, NY: Macmillan Publishing; 1980.
55. Duane TD, Jaeger EA, eds. Biomedical Foundations of Ophthalmology. Philadelphia, PA: Harper and Row, Lippincott Williams & Wilkins; 2004.
56. Sylvania FAQ. 0016-0297. Bulletin on Lumens and Mesopic Vision. 2000. Available at: http://www.sylvania.com. Accessed June 8, 2004.
57. Cicerone CM, Nerger JL. The relative numbers of long-wavelength-sensitive to middle-wavelength-sensitive cones in the human fovea centralis. Vision Res. 1989;29:115-128.
58. Magnussen S, Spillmann L, Sturzel F, et al. Filling-in of the foveal blue scotoma. Vision Res. 2001;41:2961-2967.
59. Magnussen S, Spillmann L, Sturzel F, et al. Unveiling the foveal blue scotoma through an afterimage. Vision Res. 2004;44:377-383.
60. CZE Publication No 81. Mesopic Photometry: History, Special Problems and Practical Solutions. Vienna: CIE Central Bureau; 1989.
61. Colvard M. Defining mesopic and scotopic. J Cataract Refract Surg Lett. 2003;29:6-7.
62. Gunkel RD, Gouras P. Changes in scotopic visibility thresholds with age. Arch Ophthalmol. 1963;69:38-43.
63. Jackson GR, Owsley C, Cordle EP, et al. Aging and scotopic sensitivity. Visiom Res. 1998; 38:3655-3662.
64. Jackson GR, Owsley C. Scotopic sensitivity during adulthood. Vision Res. 2000;40:2467-2473.
65. Domey RG, McFarland RA, Chadwick E. Dark adaptation as a function of age and time: II A derivation. J Gerontol. 1960;15:267-279.
66. Jackson GR, Owsley C, McGwin G Jr. Aging and dark adaptation. Vision Res. 1999;39: 3975-3982.
67. Eisner A, Fleming SA, Klein ML, et al. Sensitivities of older eyes with good acuity: Cross-sectional norms. Invest Ophthalmol Vis Sci. 1987;28:1824-1831.
68. Johnson CA, Adams AJ, Twelker JD, et al. Age-related changes of the central visual field for short-wavelength-sensitivity pathways. J Opt Soc Am. 1988;A5:2131-2139.
69. Werner JS, Steele VG. Sensitivies of human foveal color mechanisms throughout the life span. J Opt Soc Am. 1988;A5:2122-2130.
70. Schefrin BE, Werner JS, Plach M, et al. Sites of age-related sensitivity loss in a short-wave cone pathway. J Opt Soc Am. 1992;A9:355-363.
71. Lakowski R. Is the deterioration of colour discrimination with age due to lens or retinal changes? Die Farbe. 1962;11:69-86.
72. Ohta Y, Kato H. Colour perception changes with age. Mod Probl Ophthalmol. 1976;17: 345-352.
73. Knoblauch K, Saunders F, Kusuda M, et al. Age and illuminance effects in the Fransworth-Munsell 100 Hue test. Appl Opt. 1987;26:1441-1448.
74. Schefrin BE, Shinomori K, Werner JS. Contributions of neural pathways to age-related losses in chromatic discrimination. J Opt Soc Am. 1995;A12:1233-1241.
75. Derefeldt G, Lennerstrand G, Lundh B. Age variations in normal human contrast sensitivity. Acta Ophthalmol Scand. 1979;57:679-690.
76. Higgins KE, Jafe MJ, Caruso RC, et al. Spatial contrast sensitivity: effects of age, test retest, and psychophysical method. J Opt Soc Am. 1988;A5:2173-2180.
77. Tulunay-Keesey U, Ver Hoeve JN, Terkla-McGrane C. Threshold and suprathreshold spatiotemporal response throughout adulthood. J Opt Soc Am. 1988;A5:2191-2200.
78. Schefrin BE, Tregear SJ, Harvey LO Jr, et al. Senescent changes in scotopic contrast sensitivity. Vision Res. 1999;39:3728-3736.
79. Frisen L, Frisen M. How good is normal acuity? A study of letter acuity as a function of age. Graefes Arch Clin Exp Ophthalmol. 1981;215:149-157.
80. Elliot DB, Yang KCH, Whitaker D. Visual changes throughout adulthood in normal healthy eyes: seeing beyond 6/6. Optom Vis Sci. 1995;72:186-191.
81. Johnson CA, Adams AJ, Lewis RA. Evidence for a neural basis of age-related visual field loss in normal observers. Invest Ophthalmol Vis Sci 1989;30:2056-2064.
82. Coppinger NW. The relationship between critical flicker frequency and chronological age for varying levels of stimulus brightness. J Gerontol. 1955;10:48-52.
83. Kim CBY, Kayer MJ. Flicker sensitivity inn healthy aging eyes: II. Cross-sectional aging trends from 18 through 77 years of age. J Opt Soc Am. 1994;A11:1958-1969.
84. Bell MD, Wolf E, Bernholz CD. Depth perception as a function of age. Aging Human Dev. 1972;3:77-81.
85. Enoch JM, Werner JS, Haegerstrom-Portnoy G, et al. Forever young. Visual functions not affected or minimally affected by aging. J Gerontol Bio Sci. 1999;A54: B336-B351.
86. Kraft JM, Werner JS. Spectral efficiency across the life span: flicker photometry and brightness matching. J Opt Soc Am. 1994;A11:1213-1221.
87. Kraft JM, Werner JS. Aging and the saturation of colors: 2. Scaling of color appearance. J Opt Soc Am. 1999;A16:231-235.
88. Werner JS. Visual problems of the retina during ageing: compensation mechanisms and colour constancy across the life span. Prog Retin Eye Res. 1996;15:621-645.
89. Mellerio J. The interaction of light with biological tissues and the potential for damage. In: Marshall J., ed. The Susceptible Visual Apparatus. Vision and Visual Dysfunction. Vol. 16. Boca Raton, FL: CRC Press; 1991.
90. Young RW. The renewal of photoreceptor cell outer segments. J Cell Biol. 1971;33: 61-72.
91. Young RW. Visual cells and the concept of renewal. Invest Ophthalmol Vis Sci. 1976;15: 700-725.
92. Curcio CA, Millican CA, Allen KA, et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278-3296.
93. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41:2015-2018.
94. Owsley C, Jackson GR, White M, et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
95. van der Hoeve J. Senile maculadegeneration and senile Linsentrubung. Graefe Arch Ophthamol. 1918;98:1-6.
96. van der Hoeve J. Eye lesions produced by light rich in ultraviolet rays. Senile cataract, senile degeneration of the macula. Am J Ophthalmol. 1920;3:178-194.
97. Sperduto RD, Hiller R, Siegel D. Lens opacities and senile maculopathy. Arch Ophthalmol. 1981;99:1004-1008.
98. Lamb LE, Simon JD. A2E: a component of ocular lipofuscin. Photochem Photobiol. 2004; 79:127-136.
99. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981-1989.
100. Sparrow JR, Vollmer-Snarr HR, Zhou J, et al. A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem. 2003;278:18207-18213.
101. Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30:873-878.
102. Winkler BS, Boulton ME, Gottsch JD, et al. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:32.
103. Wald G. Blue blindness in the normal fovea. J Opt Soc Am. 1967;57:1289-1301.
104. Ham WT Jr, Ruffolo JJ Jr, Mueller HA, et al. The nature of retinal radiation damage: dependence on wavelength, power level and exposure time. Vision Res. 1980;20:1105-1111.
105. Kremers JJ, van Norren D. Two classes of photochemical damage of the retina. Lasers Light Ophthalmol. 1988;2:41-52.
106. Marshall JM, ed. The Susceptible Visual Apparatus. Vision and Visual dysfunction. Vol. 16. Boca Raton, FL: CRC Press; 1991.
107. Mellerio J. Light effects on the retina. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, PA: W.B. Saunders; 1994:1326-1345.
108. Glickman RD. Phototoxicity to retina: mechanisms of damage. Int J Toxicol. 2002;21: 473-490.
109. Noell WK, Walker VS, Kang BS, et al. Retinal damage by lights in rats. Invest Ophthalmol Vis Sci. 1966;5:450-473.
110. Marshall J, Mellerio J, Palmer DA. Damage to pigeon retina by commercial light sources operating at moderate levels. Vision Res. 1971;11:1198-1199.
111. Sykes SM, Robison WG Jr, Waxler M, et al. Damage to the monkey retina by broad-spectrum fluorescent light. Invest Ophthalmol Vis Sci. 1981;20:425-434.
112. Guduz K, Arden GB. Changes in colour contrast sensitivity associated with operating argon lasers. Br J Ophthalmol. 1989;73:241-246.
113. Ham WT, Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature. 1976;260:153-155.
114. Ham WT, Mueller HA, Ruffolo JJ, et al. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol. 1982;93: 299-306.
115. Ruffolo JJ Jr, Ham WT Jr, Mueller HA, et al. Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest Ophthalmol Vis Sci. 1984;25: 893-898.
116. Crockett RS, Lawill T. Oxygen dependence of damage by 435 nm light in cultured retinal epithelium. Curr Eye Res. 1984;3:209-215.
117. Griess GA, Blankenstein MF. Additively and repair of actinic retinal lesions. Invest Ophthalmol Vis Sci. 1981;20:803-807.
118. Werner JS, Steele VG, Pfoff DS. Loss of human photoreceptor sensitivity associated with chronic radiation. Ophthalmology. 1989;96:1552-1558.
119. Savage GL, Haegerstrom-Portnoy G. S-cone sensitivity in unilateral aphakia. Optom Vis Sci. 1994;71:17-22.
120. Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997;38:557-568.
121. Klein BE, Lein R, Lee KE, et al. Associations of performance-based and self-reported measures of visual function. The Beaver Dam Eye Study. Ophthalmic Epidemiol. 1999;6: 49-60.
122. Ivers RQ, Mitchell P, Gumming RG. Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. Clin Experiment Ophthalmol. 2000;28: 41-47.
123. Brabyn J, Schneck M, Naegerstrom-Portnoy G, et al. The Smith-Kettlewell Institute (SKI) longitudinal study of vision function and its impact among the elderly: an overview. Optom Vis Sci. 2001;78:264-269.
124. Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987;237:143-149.
125. Owsley C, Burton K. Aging and spatial contrast sensitivity: underlying mechanisms and implications for everyday life. In: Bagnoli P, Hodos W, eds. The Changing Visual System. New York, NY: Plenum Press; 1991:119-136.
126. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health. 1989;79:765-769.
127. Taylor HR, Munoz B, West S, et al. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc. 1990;88:163-173.
128. Taylor HR, West S, Munoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol. 1992;110:99-104.
129. Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol. 1993;111:514-518.
130. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology. 1997;104:770-776.
131. Cruickshanks KJ, Klein R, Klein BE, et al. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2001;119:246-250.
132. Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l'Age (POLA) study. Arch Ophthalmol. 2001;119:1463-1468.
133. McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol. 2001;119:1455-1462.
134. Oliver M. Posterior pole changes after cataract extraction in elderly subjects. Am J Ophthalmol. 1966;62:1145-1148.
135. Armbrecht AM, Findlay C, Kaushal S, et al. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol. 2000;84:1343-1348.
136. Wong TY. Cataract surgery in patients with cataract and age-related macular degeneration: do the benefits outweigh the risks? Br J Ophthalmol. 2000;84:1337-1338.
137. Klein R, Klein BE, Wong TY, et al. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol. 2002;120:1551-1558.
138. Armbrecht AM, Findlay C, Aspinall PA, et al. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg. 2003;29:686-693.
139. Freeman EE, Munoz B, West SK, et al. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol. 2003;135:849-856.
140. Klein R, Klein BEK, Wang Q, et al. Is age-related maculopathy associated with cataracts? Arch Ophthalmol. 1994;112:191-196.
141. Wang JJ, Mitchell PG, Cumming RG, et al. Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 1999;6:317-326.
142. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
143. Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol. 1992;110:381-387.
144. Katz J, Zeger S, Liang KY. Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes. Invest Ophthalmol Vis Sci. 1994;35:2461-2465.
145. The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367-374.
146. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206-217.
147. Hyman LG, Lilienfeld AM, Ferris FL 3rd, et al. Senile macular degeneration: A case-control study. Am J Epidemiol. 1983;118:213-227.
148. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93:552-558.
149. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1708.
150. Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration: Age-Related Macular Degeneration risk factors study group. Arch Ophthalmol. 2000;117:351-358.
151. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye study. Ophthalmology. 2002;109:1767-1779.
152. van Leeuwen R, Klaver CC, Vingerling JR, et al. The risk and natural course of age-related maculopathy: Follow-up at 6 and half years in the Rotterdam study [Erratum in Arch Ophthalmol. 2003;121:955]. Arch Ophthalmol. 2003;121:519-526.
153. van Leeuwen R, Klaver CC, Vingerling JR, et al. The risk and natural course of age-related maculopathy: Follow-up at 6 and half years in the Rotterdam study [Erratum in Arch Ophthalmol. 2003;121:955]. Arch Ophthalmol. 2003;121:519-526.
154. Wang JJ, Foran S, Smith W, et al. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye study cohort. Arch Ophthalmol. 2003;121:658-663.
155. Report No AREDS. 8. A randomized placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119:1417-1436.
156. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology. 2001;108:697-704.
157. Klein BE, Klein R, Lee KE, et al. Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye study. Am J Epidemiol. 2001;154:207-211.
158. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy: population-based familial aggregate study. Arch Ophthalmol. 1998;116:1646-1651.
159. Paetkau ME, Boyd TA, Grace M, et al. Senile disciform macular degeneration and smoking. Can J Ophthalmol. 1978;13:67-71.
160. Klein R, Klein BE, Linton KL, et al. The Beaver Dam Eye study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190-200.
161. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy: the Blue Mountain Eye study. Arch Ophthalmol. 1996;114:1518-1523.
162. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996;276:1141-1146.
163. Christen WG, Glynn RJ, Manson JE, et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996;276:1147-1151.
164. Delcourt C, Diaz JL, Ponton-Sanchez A, et al. Smoking and age-related macular degeneration. The POLA Study [in French]. Arch Ophthalmol. 1998;116:1031-1035.
165. Mitchell P, Wang JJ, Smith W, et al. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye study. Arch Ophthalmol. 2002;120:1357-1363.
166. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence of age-related maculopathy an smoking and drinking: the Beaver Dam Eye study. Am J Epidemiol. 2002;156:589-598.
167. Bischoff PM, Flower RW. High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration. Am J Ophthalmol. 1983;96: 398-399.
168. Pauleikhoff D, Chen JC, Chisholm IH, et al. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol. 1990;109:211-217.
169. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2000;130:658-663.
170. van Leeuwen R, Ikram MK, Vingerling JR, et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam study. Invest Ophthalmol Vis Sci. 2003;44:3771-3777.
171. Smith W, Mitchell P, Leeder SR, et al. Plasma fibrinogen, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye study. Arch Ophthalmol. 1998;116:583-587.
172. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities study. Arch Ophthalmol. 1999;117:1203-1210.
173. Klein R, Klein BE, Jensen SC, et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106:1056-1065.
174. Delcourt C, Michel LF, Colvez A, et al, for the POLA Study Group. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249.
175. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the Cardiovascular Health study. Ophthalmology. 2003;110:25-33.
176. Klein R, Klein BE, Tomany SC, et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam Eye study. Ophthalmology. 2003;110:1273-1280.
177. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis, MO: Mosby; 1999:31-55.
178. van Leeuwen R, Vingerling JR, Hofman A, et al. Cholesterol lowering drugs and risk of age related maculopathy: Prospective cohort study with cumulative exposure measurement. Br Med J. 2003;226:255-256.
179. Klein R, Klein BE, Tomany SC, et al. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol. 2003;121:1151-1155.
180. Kornzweig AL. Changes in the choriocapillaris associated with senile macular degeneration. Ann Ophthalmol 1977;9:753-756.
181. Martinez GS, Campbell AJ, Reinken J, et al. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol. 1982;94:181-189.
182. Pauleikhoff D, Wormald RP, Wright L, et al. Macular disease in an elderly population. Ger J Ophthalmol. 1992;1:12-15.
183. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2004; 111:1280-1287.
184. Wang JJ, Klein R, Smith W, et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology. 2003;110:1960-1967.
185. Weiter JJ, Delori FC, Wing GL, et al. Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol. 1985;99:185-187.
186. Vinding T. Pigmentation of the eye and hair in relation to age-related macular degeneration: an epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh). 1990;68:53-58.
187. Holtz FG, Piguet B, Minassian DC, et al. Decreasing stromal iris pigmentation as a risk factor of age-related macular degeneration. Am J Ophthalmol. 1994;117:19-23.
188. Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy: the Blue Mountain Eye study. Ophthalmology. 1998;105:1359-1363.
189. Frank RN, Puklin JE, Stock C, et al. Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc. 2000;98:109-115, discussion 115-117.
190. Ikram MK, van Leeuwen R, Vingerling JR, et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam study. Invest Ophthalmol Vis Sci. 2003;44:3778-3782.
191. Tomany SC, Klein R, Klein BE. The relationship between iris color, hair color, and skin sun sensitivity to the 10-year incidence of age-related maculopathy: The Beaver Dam Eye study. Ophthalmology. 2003;110:1526-1533.
192. Hiller R, Sperduto RD, Ederer F. Epidemiologic association with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986;124:916-925.
193. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med. 1988;319:1429-1433.
194. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989;107:875-879.
195. Roberts JE. Ocular phototoxicity. J Photochem Photobiol B. 2001;64:136-143.
196. Cruickshanks KJ, Klein BE, Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health. 1992;82:1658-1662.
197. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation Project. JAMA. 1998;280:714-718.
198. Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées a l'Age (POLA) study. Arch Ophthalmol. 2000;118:383-392.
199. Holman CDJ, Evans PR, Lumsden GJ, et al. The determinants of actinic skin damage: problems of confounding among environmental and constitutional variables. Am J Epidemiol. 1984;120:414-422.
200. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. The Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci. 1997;38:72-82.
201. Lerman S, Borkman R. Ultraviolet radiation in the aging and cataractous lens: a survey. Acta Ophthalmol Scand. 1978;56:139-149.
202. Bellows JG. Light: a double-edged sword. Ann Ophthalmol. 1971;3:687-688.
203. Byrnes GA, Antoszyk AN, Mazur DO, et al. Photic maculopathy after extracapsular cataract surgery: a prospective study. Ophthalmology. 1992;99:731-738.
204. Khwarg SG, Linstone FA, Daniels SA, et al. Incidence, risk factors, and morphology in operating microscope light retinopathy. Am J Ophthalmol. 1987;103:255-263.
205. Mainster MA, Ham WT Jr, Delori FC. Potential retinal hazards: instrument and environmental light sources. Ophthalmology. 1983;90:927-932.
206. McDonald HR, Irvine AR. Light-induced maculopathy from the operating microscope in extracapsular cataract extraction and intraocular lens implantation. Ophthalmology. 1983;90:945-951.
207. Kleinmann G, Hoffman P, Schechtman E, et al. Microscope-induced retinal phototoxicity in cataract surgery of short duration. Ophthalmology. 2002;109:334-338.
208. Jaffe NS. The intracapsular-extracapsular controversy. Aust J Ophthalmol. 1982;10:115-119.
209. Allen AW, Zhang HR. Extracapsular cataract extraction: prognosis and complications with and without posterior-chamber lens implantations. Ann Ophthalmol. 1987;19:329-333.
210. Severin TD, Severin SL. Pseudophakic cystoid macular edema: a revised comparison of the incidence with intracapsular and extracapsular cataract extraction. Ophthalmic Surg. 1988;19:116-118.
211. West SK, Klein R, Rodriguez J, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24:1204-1209.
212. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol. 1990;108:286-290.
213. Klein BE, Klein R, Moss SE. Incident cataract surgery: the Beaver Dam Eye study. Ophthalmology. 1997;104:573-580.
214. United Nations. Population Division. World Population Projections to 2150. New York, NY: United Nations; 1998.